Scientists map cancer-related proteins in unprecedented detail

byInstitute of Cancer ResearchStructures and interactions of the CSN–CRL2~N8 complex. Image also shows the molecular model of CSN–CRL2~N8 fitted into cryo-EM density (8.2 Å resolution) from fron

Updated on: December 22,2023

Scientists map cancer-related proteins in unprecedented detail

byInstitute of Cancer ResearchStructures and interactions of the CSN–CRL2~N8 complex. Image also shows the molecular model of CSN–CRL2~N8 fitted into cryo-EM density (8.2 Å resolution) from fron

Updated on:December 22,2023

New study may lead to fewer hysterectomies in women with uterine fibroid tumors

by Geri Kelley, Kim Ward,Michigan State UniversityCredit: Michigan State UniversityUterine fibroid tumors are the leading cause of hysterectomies in the U.S., yet little is known about what caus

Updated on: December 22,2023

New study may lead to fewer hysterectomies in women with uterine fibroid tumors

by Geri Kelley, Kim Ward,Michigan State UniversityCredit: Michigan State UniversityUterine fibroid tumors are the leading cause of hysterectomies in the U.S., yet little is known about what caus

Updated on:December 22,2023

Insurance disparities ID'd in diagnosis of late-stage melanoma

For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with having private insurance,

Updated on: December 22,2023

Insurance disparities ID'd in diagnosis of late-stage melanoma

For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with having private insurance,

Updated on:December 22,2023

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on: April 28,2024

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on:April 28,2024

Looking at the environment around tumors could help predict how cancer spreads

byUniversity College LondonRepresentative images of high granulocyte infiltration in the tumor nest and stroma for LUAD (left) and LUSC (right). Credit:Cancer Discovery(2024). DOI: 1

Updated on: April 28,2024

Looking at the environment around tumors could help predict how cancer spreads

byUniversity College LondonRepresentative images of high granulocyte infiltration in the tumor nest and stroma for LUAD (left) and LUSC (right). Credit:Cancer Discovery(2024). DOI: 1

Updated on:April 28,2024

How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

by Niyati Jain,University of ChicagoDifferential expression of gene pathways in BCC (in blue) compared to healthy skin tissue (in red) by PTCH1 mutational status. BCC tissues with no non-synonym

Updated on: December 01,2024

How the environment is silently shaping cancer risk: Data helps untangle links between pollution and cancer

by Niyati Jain,University of ChicagoDifferential expression of gene pathways in BCC (in blue) compared to healthy skin tissue (in red) by PTCH1 mutational status. BCC tissues with no non-synonym

Updated on:December 01,2024

Understanding early effects of psoriasis drug offers potential for personalized treatment

by King's College LondonDiagram showing the early effects of therapeutic IL-23 inhibition. Left: in lesional psoriasis skin, IL-23 drives the differentiation of T17 cells. Right: following IL

Updated on: May 06,2024

Understanding early effects of psoriasis drug offers potential for personalized treatment

by King's College LondonDiagram showing the early effects of therapeutic IL-23 inhibition. Left: in lesional psoriasis skin, IL-23 drives the differentiation of T17 cells. Right: following IL

Updated on:May 06,2024

Natural compounds derived from soy and other plants found to reduce breast cancer recurrence and improve survival

JANUARY 10, 2024Natural compounds derived from soy and other plants found to reduce breast cancer recurrence and improve survivalbyJohns Hopkins University School of MedicineFlow diagram of the

Updated on: March 15,2024

Natural compounds derived from soy and other plants found to reduce breast cancer recurrence and improve survival

JANUARY 10, 2024Natural compounds derived from soy and other plants found to reduce breast cancer recurrence and improve survivalbyJohns Hopkins University School of MedicineFlow diagram of the

Updated on:March 15,2024

Researcher puts focus on the health of Latina breast cancer survivors

by Katharine Gammon,University of Southern CaliforniaCredit: AI-generated imageBreast cancer is the leading cause of cancer death among Latinas in the United States. Latinas are also twice as li

Updated on: June 11,2024

Researcher puts focus on the health of Latina breast cancer survivors

by Katharine Gammon,University of Southern CaliforniaCredit: AI-generated imageBreast cancer is the leading cause of cancer death among Latinas in the United States. Latinas are also twice as li

Updated on:June 11,2024

Local radiotherapy improves survival in metastatic prostate cancer with low disease burden

byEuropean Society for Medical OncologyRadiotherapy to the prostate improves overall survival in men newly diagnosed with metastatic prostate cancer who have a low metastatic disease burden but

Updated on: December 18,2023

Local radiotherapy improves survival in metastatic prostate cancer with low disease burden

byEuropean Society for Medical OncologyRadiotherapy to the prostate improves overall survival in men newly diagnosed with metastatic prostate cancer who have a low metastatic disease burden but

Updated on:December 18,2023

Tennis legend Martina Navratilova diagnosed with throat, breast cancer

by Cara Murez HealthDay ReporterTennis legend Martina Navratilova, who won 59 grand slam titles in her career, announced Monday that she has both stage 1 breast cancer and throat cancer.Navratilova, 6

Updated on: January 08,2024

Tennis legend Martina Navratilova diagnosed with throat, breast cancer

by Cara Murez HealthDay ReporterTennis legend Martina Navratilova, who won 59 grand slam titles in her career, announced Monday that she has both stage 1 breast cancer and throat cancer.Navratilova, 6

Updated on:January 08,2024

The inaugural Sony-Nature Tech Women Award announced, with four winners

Updated on: February 17,2025

The inaugural Sony-Nature Tech Women Award announced, with four winners

Updated on:February 17,2025